Providing in-depth, accurate and valuable health information is at the core of what we do at Prenetics.
For our latest initiative, Project Screen, we have deployed our strict scientific protocols, world-class research, and advanced technology, across each of our COVID-19 testing solutions, including RT-PCR, OxLAMP, Antigen, and Antibody.
Pre-Covid our business focused on providing personalised preventative health solutions via DNA and blood tests. Our company’s mission has always been to make complex science accessible via a range of innovative self-collection test kits. In 2020, we adapted and evolved into COVID-19 testing, taking advantage of our laboratory network, scientific expertise, and digital systems to deliver world-leading COVID-19 testing solutions.
RT-PCR is recognised as the leading COVID-19 testing method, to detect viral RNA of SARS-CoV-2
OxLAMP testing is a point of care, swab-based protocol for the detection of the SARS-CoV-2 virus.
Lateral flow tests perform well with high viral loads, helping to determine if someone is infectious with coronavirus within 20 minutes.
All PCR samples are sent to UK-based laboratories for analysis. Prenetics EMEA Ltd is UKAS accredited to ISO 15189 (Medical Laboratories) and ISO 22870 (Point of Care Testing) under the unique reference number 22222. Our laboratory partners are UKAS accredited or UKAS applicants, and DHSC validated.